Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. disease mechanisms
Show results for
Products
Services
Software
Applications

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • Older

Disease Mechanisms Articles & Analysis

58 news found

Protheragen Announces Vaccine Development Services Targeting Rare Infectious Diseases

Protheragen Announces Vaccine Development Services Targeting Rare Infectious Diseases

Infectious diseases are disorders caused by organisms — such as bacteria, viruses, or parasites. A vaccine is a specialized biological formulation that triggers the immune system to recognize and activate protective responses against specific disease-causing agents. With the global landscape of infectious diseases continually evolving, ...

ByProtheragen


Role of Precision Cut Lung Slices (PCLS) In Advancing COPD Preclinical Research

Role of Precision Cut Lung Slices (PCLS) In Advancing COPD Preclinical Research

Chronic Obstructive Pulmonary Disease (COPD) is a global health burden characterized by persistent airflow limitation and progressive lung damage. ...

BySCIREQ - an emka TECHNOLOGIES Company


Mastering Tissue Dissociation - Episode 4: The Spleen

Mastering Tissue Dissociation - Episode 4: The Spleen

This precise dissociation is pivotal for advancing studies on immune response and related disease mechanisms. Read the application note EPISODE 1: THE HEART EPISODE 2: THE LUNG EPISODE 3: THE LIVER ...

ByBertin Technologies


Ace Therapeutics Releases Cardiovascular Disease Model Development Services to Power Up Related Preclinical Research

Ace Therapeutics Releases Cardiovascular Disease Model Development Services to Power Up Related Preclinical Research

Ace Therapeutics is proud to announce the launch of its cardiovascular disease model development services, aiming to empower researchers and pharmaceutical companies with advanced tools and models to accelerate the study of cardiovascular diseases and drug discovery. ...

ByAce Therapeutics


Validating The BLEO-Induced Mouse Model For Drug Discovery

Validating The BLEO-Induced Mouse Model For Drug Discovery

Idiopathic pulmonary fibrosis (IPF) is a devastating disease characterized by progressive scarring of the lungs, which severely impairs lung function over time. Developing effective treatments for IPF has been a challenge for the medical community, as the mechanisms driving this disease are complex and not fully understood. To accelerate drug ...

BySCIREQ - an emka TECHNOLOGIES Company


Mastering Tissue Dissociation - Episode 2: The Lung

Mastering Tissue Dissociation - Episode 2: The Lung

Obtaining viable single cells from lung tissue is essential for understanding respiratory function and disease mechanisms. Despite its importance, isolating these cells remains challenging. ...

ByBertin Technologies


CD BioGlyco Updated Its Glycoprotein Quantification Service Recently

CD BioGlyco Updated Its Glycoprotein Quantification Service Recently

This enhancement aims to offer more precise and comprehensive glycoprotein analysis, catering to the growing demands in the fields of biomedical research, disease biomarker discovery, and therapeutic development. Protein glycosylation, a major post-translational modification, significantly impacts protein folding, stability, and activity. Changes in glycoprotein abundance and ...

ByCD BioGlyco.


Ace Therapeutics Releases Diabetic Mouse Models for Preclinical Diabetes Research

Ace Therapeutics Releases Diabetic Mouse Models for Preclinical Diabetes Research

These models have been specifically designed to enable research on different types of diabetes including type 1, type 2, and gestational diabetes, providing valuable insights into disease mechanisms and potential treatment options. Diabetes mellitus is a chronic, systemic, metabolic disease caused by the long-term combination of genetic factors ...

ByAce Therapeutics


Ace Therapeutics Accelerates Preclinical GI and Hepatology Research with Disease Model Customization Services

Ace Therapeutics Accelerates Preclinical GI and Hepatology Research with Disease Model Customization Services

Ace Therapeutics is a preclinical contract research provider engaged in metabolic disorders, infectious diseases and parasites, neurological disorders, ophthalmic diseases, gastrointestinal disorders, and immune system diseases. ...

ByAce Therapeutics


Creative Enzymes Introduces Recombinant Porcine Citrate Synthase with Enhanced C-His Tag for Accelerated Metabolic Research

Creative Enzymes Introduces Recombinant Porcine Citrate Synthase with Enhanced C-His Tag for Accelerated Metabolic Research

Whether you are investigating the role of citrate synthase in disease mechanisms, optimizing biofuel production, or exploring the intricacies of mitochondrial function, this enzyme from Creative Enzymes is a powerful tool that can propel your research forward. ...

ByCreative Enzymes


CD BioSciences Announces Comprehensive Range of Nervous System Tissue Microarrays

CD BioSciences Announces Comprehensive Range of Nervous System Tissue Microarrays

This comprehensive collection provides researchers with a unique resource to study various neurological conditions and accelerate their investigations into neurological diseases and disorders. CD Bioscience has been developing imaging technologies for many years and uses high content imaging, nanoparticle imaging, imaging flow cytometry, time-lapse imaging and other technologies ...

ByCD BioSciences


Multi-Type Animal Cognitive Behavioral Tests for Disease Research

Multi-Type Animal Cognitive Behavioral Tests for Disease Research

In the pursuit of advancing disease research and its treatment, animal cognitive behavior is studied in a wide range of animal species. ...

ByProtheragen


Animal Emotional Behavior Tests for Anxiety and Depression Treatment

Animal Emotional Behavior Tests for Anxiety and Depression Treatment

Depression is commonly seen in neurodegenerative and neurodevelopmental diseases such as Alzheimer's disease, Parkinson's disease, Huntington's disease, and autism spectrum disorders. Although the exact mechanisms are not fully understood, it is believed that anxiety and depression are caused by a combination of ...

ByProtheragen


CD Genomics Introduces Cutting-Edge Degradome Sequencing Service Redefining Transcriptomics Research

CD Genomics Introduces Cutting-Edge Degradome Sequencing Service Redefining Transcriptomics Research

This state-of-the-art technology enables scientists to pinpoint and characterize actively degrading RNA molecules, shedding new light on essential regulatory mechanisms. Key Highlights of CD Genomics' Degradome Sequencing Service: High-Precision Data: CD Genomics employs a cutting-edge sequencing platform that produces high-precision data with exceptional resolution. ...

ByCD Genomics


CD Genomics Unveils A Pioneering Genomics Approach—Long Amplicon Analysis (LAA) Service

CD Genomics Unveils A Pioneering Genomics Approach—Long Amplicon Analysis (LAA) Service

Investigation of Complex Genomic Regions: LAA empowers scientists to delve into complex genomic regions that hold critical biological insights, such as regulatory elements, disease-related genes, and repetitive sequences. 3. Targeted Gene Analysis: Offering an economical and efficient solution for targeted gene analysis, LAA proves ideal for studying specific regions of ...

ByCD Genomics


Creative Proteomics Debuts Far-Western Blot Analysis Service to Advance Proteomics Research

Creative Proteomics Debuts Far-Western Blot Analysis Service to Advance Proteomics Research

Gaining a deeper understanding of these intricate interactions is essential for deciphering disease mechanisms and identifying potential therapeutic targets. Far-Western Blot Analysis emerges as a powerful tool, allowing researchers to delve into the intricacies of protein networks, uncovering vital information about protein binding partners and unraveling the ...

ByCreative Proteomics


CD Genomics Introduces Advanced Exosomal RNA Sequencing Service for Enhanced Molecular Insights

CD Genomics Introduces Advanced Exosomal RNA Sequencing Service for Enhanced Molecular Insights

The analysis of exosomal RNA content is crucial for unraveling their roles in health and disease. CD Genomics' Exosomal RNA Sequencing service utilizes state-of-the-art next-generation sequencing (NGS) technologies, enabling high-throughput and cost-effective analysis of exosomal RNA samples. ...

ByCD Genomics


Simplify Your Microbiome Research with MicrobioSeq’s Microbial Biomarker Discovery Service

Simplify Your Microbiome Research with MicrobioSeq’s Microbial Biomarker Discovery Service

By identifying microbial biomarkers that are associated with specific diseases or conditions, the service can provide valuable insights into the underlying biological mechanisms of these diseases. With its advanced technological platform and cutting-edge sequencing and analysis algorithms, this service is designed to accurately and efficiently ...

ByCD Genomics


Inversago Pharma Doses First Patient in Phase 2 Trial of INV-202, an Oral, Peripherally-acting CB1 Inverse Agonist, in Patients with Diabetic Kidney Disease

Inversago Pharma Doses First Patient in Phase 2 Trial of INV-202, an Oral, Peripherally-acting CB1 Inverse Agonist, in Patients with Diabetic Kidney Disease

The therapeutic effects of a peripheral CB1 blockade in a range of cardiometabolic and fibrotic diseases are well-documented, paving the way for potential treatment of a large number of patients with current unmet needs. About Diabetic Kidney Disease DKD is a chronic progressive disease that accounts for more than 50% of end-stage renal ...

ByInversago Pharma


HemoShear Therapeutics to Participate in Piper Sandler Healthcare Conference

HemoShear Therapeutics to Participate in Piper Sandler Healthcare Conference

About HemoShear Therapeutics HemoShear Therapeutics, Inc. is a privately held clinical stage company developing treatments for rare diseases with significant unmet patient need. HemoShear’s drug discovery platform, REVEAL-Tx™, enables the Company’s scientists to create best-in-class, biologically relevant human disease models to uncover the ...

ByHemoShear Therapeutics, Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT